According to GlobalData’s medical device pipeline database, 58 Glaucoma Surgery Devices devices are in various stages of development globally. GlobalData’s report Glaucoma Surgery Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 34 are in active development, while the remaining 24 are in an inactive stage of development. There are 16 products in the early stages of development, and the remaining 18 are in the late stages of development.
Glaucoma Surgery Devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. This category includes glaucoma drainage devices and Minimally Invasive Glaucoma Surgery (MIGS). One unit refers to one Glaucoma Surgery Device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Glaucoma Surgery Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Glaucoma Surgery Devices devices. Overall, most of these Glaucoma Surgery Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Glaucoma Surgery Devices include Liqid Medical, iSTAR Medical, HiSilicon (Suzhou) Biomedical Technology, Suzhou Langmu Medical Technology, Tel Aviv University, University of Colorado, Sight Sciences, Stanford University, Stanford University and University of Colorado Anschutz Medical Campus.
For a complete picture of the developmental pipeline for Glaucoma Surgery Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
